Apoptotic and proliferative indexes in esophageal cancer: Predictors of response to neoadjuvant therapy apoptosis and proliferation in esophageal cancer

Journal of Gastrointestinal Surgery

Volumn 7, Issue 1, 2003, Pages 77-87

  Beardsmore, Duncan M ^a   Verbeke, Caroline S ^a   Davies, Claire L ^a   Guillou, Pierre J ^a   Clark, Geoffrey W B ^a   Shibata, D ^b   Peters, Jeffrey H ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Apoptosis; bcl 2; Esophageal cancer; Neoadjuvant therapy; p53; Proliferation; Survivin

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; PROTEIN BCL 2; PROTEIN P53; SURVIVIN; BIRC5 PROTEIN, HUMAN; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CANCER SURGERY; CELL ACTIVITY; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ESOPHAGUS CARCINOMA; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PREDICTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR BIOPSY; ADENOCARCINOMA; ADJUVANT THERAPY; CELL DIVISION; CHEMISTRY; ESOPHAGUS TUMOR; MIDDLE AGED; PATHOPHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037267871     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00141-5     Document Type: Article

References (26)

1. Kelsen D.P., Ginsberg R., Pajak T.F., Sheahan D.G., Gunderson L., Mortimer J., Estes N., Haller D.G., Ajani J., Kocha W., Minsky B.D., Roth J.A. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 339:1998;1979-1984.
2. Medical Research Council (MRC) Upper GI Tract Cancer Group. Medical Research Council (MRC) randomised phase III trial of surgery with or without pre-operative chemotherapy in resectable cancer of the oesophagus [abstr]. Br J Cancer 2000;83(Suppl 1):1.
3. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P.J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1996;462-467.
4. Bosset J.F., Gignoux M., Triboulet J.P., Tiret E., Mantion G., Elias D. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 337:1996;161-167.
5. Kerr J.F., Winterford C.M., Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy Cancer. 73:1994;2013-2226.
6. Lane D.P. P53, guardian of the genome. Nature. 358:1992;15-16.
7. McConkey D.J., Chandra J., Wright S., Plunkett W., McDonnell T.J., Reed J.C., Keating M. Apoptosis sensitivity in chronic lymphocytic leukaemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol. 156:1996;2624-2630.
8. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 3:1997;917-921.
9. Deveraux Q.L., Reed J.C. IAP family proteins - Suppressors of apoptosis. Genes Dev. 13:1999;239-252.
10. Ambrosini G., Adida C., Sirugo G., Altieri D.C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem. 273:1998;11177-11182.
11. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 396:1998;580-584.
12. Kawasaki H., Altieri D.C., Lu C.-D., Toyoda M., Tenjo T., Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:1998;5071-5074.
13. Sarela A.I., Macadam R.C., Farmery S.M., Markham A.F., Guillou P.J. Expression of the anti-apoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 46:2000;645-650.
14. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 351:1999;882-883.
15. Swana H.S., Grossman D., Anthony J.N., Weiss R.M., Altieri D.C. Tumor content of the anti-apoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med. 341:1999;452-453.
16. Olie R.A., Simoes-Wust A.P., Baumann B., Leech S.H., Fabbro D., Stahel R.A., Zangemeister-Wittke U. A novel anti-sense oligonucleotide targeting survivin expression induces apoptosis and sensitises lung cancer cells to chemotherapy. Cancer Res. 60:2000;2805-2809.
17. Sarela A.I., Verbeke C.S., Ramsdale J., Davies C.L., Markham A.F., Guillou P.J. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein in pancreatic adenocarcinoma. Br J Cancer. 86:2002;886-892.
18. Kawasaki H., Toyodo M., Shinohara H., Okuda J., Watanabe I., Yamamoto T., Tanaka K., Tenjo T., Tanigawa N. Expression of survivin correlates with apoptosis, proliferation and angiogenesis during human colorectal tumorigenesis. Cancer. 91:2001;2026-2032.
19. Ito T., Shiraki K., Sugimoto K., Yamanaka T., Fujikawa K., Ito M., Takase K., Moriyama M., Kawano H., Hayashida M., Nakano T., Suzuki A. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 31:2000;1080-1085.
20. Gianini R., Jarboe E., Orlicky D., Frost M., Bobak J., Lehner R., Shroyer K.R. Expression of survivin in normal, hyperplastic and neoplastic colonic mucosa. Hum Pathol. 32:2001;119-125.
21. Fekuda S., Pelus L.M. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by haematopoietic growth factors. Implication of survivin expression in normal haematopoiesis Blood. 98:2001;2091-2100.
22. Lu C., Altieri D., Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumour cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 58:1998;1808-1812.
23. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 6:2000;127-134.
24. Katada N., Hinder R., Smyrk T.C., Hirabayashi N., Perdikis G., Lund R.J., Woodward T., Klinger P.J. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett's esophagus. Arch Surg. 132:1997;728-733.
25. Kitamura K., Sacki H., Kawaguchi H., Araki K., Ohno S., Kuwano H., Maehara Y., Sugimachi K. Immunohistochemical status of the p53 and ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterolgy. 47:2000;419-423.
26. Miyata H., Yuichiro D., Shiozaki H., Inoue M., Yano M., Fujiwara Y., Yamamoto H., Nishioka K., Kishi K., Monden M. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancer. Clin Cancer Res. 6:2000;4859-4865.